Snoring is often dismissed as a minor nuisance, but it can be a warning sign of obstructive sleep apnea (OSA)—a serious medical condition with significant cardiovascular and metabolic consequences if left untreated.

What Is Sleep Apnea?

Sleep apnea is a chronic disorder characterized by repeated interruptions to breathing during sleep. There are three primary forms:

Obstructive Sleep Apnea (OSA): The most common type, caused by physical collapse of the upper airway during sleep. OSA affects approximately 2–9% of adults in the general population, though some estimates are higher when milder cases are included [1].
Central Sleep Apnea (CSA): Less common; the airway remains open but the brain fails to send proper signals to the breathing muscles.
Complex (Mixed) Sleep Apnea: A combination of obstructive and central components, sometimes emerging during CPAP therapy.

OSA occurs when throat muscles relax and the soft tissue at the back of the throat collapses, partially or completely blocking the airway. This triggers a brief arousal that restores breathing—often so brief that the person has no memory of it—but which can occur dozens or even hundreds of times per night.

Signs and Symptoms

The hallmark symptom of OSA is loud, disruptive snoring interspersed with witnessed breathing pauses. Additional signs include:

Witnessed apneas: A bed partner or roommate observes you stop breathing during sleep
Gasping or choking: Sudden awakenings with a sensation of suffocation
Morning headaches: Result of overnight oxygen desaturation
Excessive daytime sleepiness (EDS): Unrefreshing sleep leading to profound fatigue regardless of time in bed
Difficulty concentrating and memory problems: Cognitive impairment from fragmented sleep architecture
Mood disturbances: Irritability, depression, and anxiety are significantly more common in untreated OSA
Nocturia: Frequent nighttime urination, driven by atrial natriuretic peptide release during apnea events
Dry mouth or sore throat on waking: From breathing through the mouth during airway obstruction

Not everyone with OSA snores loudly, and not everyone who snores has OSA. Evaluation by a sleep specialist is required to distinguish between the two.

Severity Classifications

The standard measure of sleep apnea severity is the Apnea-Hypopnea Index (AHI)—the average number of apnea and hypopnea events per hour of sleep. The American Academy of Sleep Medicine (AASM) defines severity categories as follows [2]:

Severity	AHI (events per hour)
Mild OSA	5–14 events per hour
Moderate OSA	15–29 events per hour
Severe OSA	30 or more events per hour

An AHI below 5 in adults is generally considered normal. Even mild OSA can produce significant daytime symptoms in some individuals, particularly those who are highly sensitive to sleep fragmentation.

The Oxygen Desaturation Index (ODI) is a complementary metric tracking how often blood oxygen falls by 3–4% per hour. Home sleep apnea tests typically report both AHI and ODI.

Risk Factors

OSA does not affect everyone equally. Major risk factors include:

Obesity: BMI > 30 is the single strongest modifiable risk factor. Excess fat deposits in the neck and pharyngeal walls narrow the airway.
Neck circumference: Greater than 17 inches (43 cm) in men or 16 inches (41 cm) in women is associated with elevated risk.
Age: Prevalence increases with age, particularly after 40.
Sex: Men are 2–3 times more likely to have OSA than premenopausal women; the gap narrows after menopause.
Alcohol and sedative use: Relax upper airway muscles, worsening obstruction.
Smoking: Increases upper airway inflammation and edema.
Family history: Genetic factors influence craniofacial anatomy and airway muscle tone.
Anatomical features: Retrognathia (recessed jaw), enlarged tonsils or adenoids, elongated soft palate, and narrow nasal passages all reduce airway diameter.
Positional sleeping: Supine (back-sleeping) position allows gravity to worsen airway collapse.

Diagnosis

Polysomnography (PSG)

The gold standard for diagnosing sleep apnea is an in-laboratory overnight polysomnography, which simultaneously records:

Airflow (nasal pressure, thermistor)
Respiratory effort (chest and abdominal belts)
Oxygen saturation (pulse oximetry)
Electroencephalogram (EEG) for sleep staging
Electrooculogram (EOG) for eye movements
Electromyogram (EMG) for muscle activity
Electrocardiogram (ECG) for cardiac rhythm

PSG provides complete sleep architecture data and the most accurate AHI measurement.

Home Sleep Apnea Testing (HSAT)

For patients with high pre-test probability of moderate-to-severe OSA and no significant comorbidities (e.g., heart failure, COPD, neuromuscular disease), HSAT using a portable multi-channel recorder is an acceptable and cost-effective alternative.

Clinical Screening Tools

The STOP-BANG questionnaire is the most widely used validated screening tool in clinical and preoperative settings. It assesses Snoring, Tiredness, Observed apneas, blood Pressure, BMI, Age, Neck circumference, and Gender. A score of 3 or more indicates high risk for moderate-to-severe OSA.

Treatment Options

Continuous Positive Airway Pressure (CPAP)

CPAP therapy is the first-line treatment for moderate-to-severe OSA, and is recommended for mild OSA with significant symptoms [3]. A CPAP machine delivers a continuous stream of pressurized air through a mask (nasal, full-face, or nasal pillow), acting as a pneumatic splint that keeps the airway open throughout the respiratory cycle.

Key points about CPAP:

Highly effective when used consistently (typically ≥4 hours/night on ≥70% of nights)
Eliminates apneas, improves oxygen saturation, and restores normal sleep architecture
Modern devices record nightly usage, residual AHI, and mask leak data
Auto-titrating PAP (APAP) adjusts pressure automatically based on detected events

Bilevel PAP (BiPAP)

BiPAP delivers separate inspiratory and expiratory pressures. It is used for central and complex sleep apnea, high-pressure requirements poorly tolerated on CPAP, and patients with comorbid respiratory conditions.

Oral Appliance Therapy (OAT)

Mandibular advancement devices (MADs) reposition the lower jaw forward, increasing posterior airway space. OAT is effective for mild-to-moderate OSA, particularly in patients who cannot tolerate CPAP. Custom-fitted devices from a dental sleep medicine specialist are more effective and better tolerated than over-the-counter alternatives.

Positional Therapy

Supine-predominant OSA (OSA that is significantly worse on the back) can be managed with devices or positional aids that prevent supine sleeping. Smartphone apps and vibrating positional devices have shown efficacy in clinical trials.

Weight Management

Weight loss is the most powerful long-term intervention for overweight and obese patients with OSA. A 10% reduction in body weight has been associated with an approximately 26% reduction in AHI [4]. Bariatric surgery produces larger and more durable weight loss and can result in remission of OSA in many patients.

Surgical Options

Surgery is generally reserved for patients who fail or cannot tolerate PAP therapy and OAT:

Uvulopalatopharyngoplasty (UPPP): Removes excess soft tissue from the soft palate and throat
Maxillomandibular Advancement (MMA): Moves both jaws forward to enlarge the skeletal airway; highly effective for anatomical OSA
Hypoglossal Nerve Stimulation (Inspire): An implanted device that activates the genioglossus muscle to protrude the tongue during inspiration, preventing airway collapse; FDA-approved for moderate-to-severe OSA in CPAP-intolerant patients

Lifestyle Modifications

Avoid alcohol within 4 hours of bedtime
Quit smoking (reduces airway inflammation)
Treat nasal congestion (allergic rhinitis, deviated septum)
Maintain consistent sleep schedule

Complications of Untreated Sleep Apnea

Untreated moderate-to-severe OSA carries significant long-term health risks. Men with severe OSA who remain untreated have substantially higher rates of fatal and non-fatal cardiovascular events compared to those treated with CPAP [5]:

Hypertension: OSA is the most common secondary cause of resistant hypertension
Coronary artery disease and heart failure: Nocturnal hypoxia, sympathetic activation, and systemic inflammation accelerate atherosclerosis
Atrial fibrillation and cardiac arrhythmia: Sleep-related oxygen desaturation is a major trigger
Stroke: OSA approximately doubles stroke risk
Metabolic syndrome and type 2 diabetes: Insulin resistance worsens with intermittent hypoxia
Motor vehicle accidents: Daytime sleepiness from OSA significantly increases accident risk—studies show 2–7 times higher crash rates in untreated patients
Cognitive impairment: Chronic sleep fragmentation and hypoxia impair memory, executive function, and attention

When to See a Doctor

Seek evaluation from a sleep specialist or your primary care physician if you:

Have been told you stop breathing or gasp during sleep
Experience excessive daytime sleepiness despite 7–9 hours of sleep
Have loud, persistent snoring that disturbs others
Wake regularly with morning headaches or dry mouth
Experience mood changes, difficulty concentrating, or declining work performance with no other clear cause
Have hypertension that is difficult to control despite medication

Early diagnosis and consistent treatment can dramatically improve sleep quality, daytime functioning, and long-term cardiovascular health. Sleep apnea is a chronic but highly manageable condition.

Snoring and Sleep Apnea: When to Be Concerned